MENU
+Compare
EMBC
Stock ticker: NASDAQ
AS OF
Jul 21, 04:59 PM (EDT)
Price
$10.30
Change
+$0.52 (+5.32%)
Capitalization
764.07M

EMBC Embecta Corp Forecast, Technical & Fundamental Analysis

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes... Show more

EMBC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for EMBC with price predictions
Jul 18, 2025

Momentum Indicator for EMBC turns negative, indicating new downward trend

EMBC saw its Momentum Indicator move below the 0 level on July 15, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 60 similar instances where the indicator turned negative. In of the 60 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for EMBC turned negative on July 18, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 30 similar instances when the indicator turned negative. In of the 30 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EMBC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for EMBC entered a downward trend on July 09, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EMBC advanced for three days, in of 179 cases, the price rose further within the following month. The odds of a continued upward trend are .

EMBC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.614) is normal, around the industry mean (24.694). P/E Ratio (13.646) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.046) settles around the average of (0.018) among similar stocks. P/S Ratio (0.675) is also within normal values, averaging (43.458).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. EMBC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EMBC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
EMBC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

EMBC is expected to report earnings to rise 10.29% to 77 cents per share on August 07

Embecta Corp EMBC Stock Earnings Reports
Q2'25
Est.
$0.77
Q1'25
Beat
by $0.17
Q4'24
Beat
by $0.16
Q3'24
Beat
by $0.09
Q2'24
Beat
by $0.28
The last earnings report on May 09 showed earnings per share of 69 cents, beating the estimate of 52 cents. With 178.44K shares outstanding, the current market capitalization sits at 764.07M.
A.I.Advisor
published Dividends

EMBC paid dividends on June 13, 2025

Embecta Corp EMBC Stock Dividends
А dividend of $0.15 per share was paid with a record date of June 13, 2025, and an ex-dividend date of May 28, 2025. Read more...
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
300 Kimball Drive
Phone
+1 862 401-0000
Employees
2200
Web
https://www.embecta.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FBSOX54.340.16
+0.30%
Fidelity Select Enterprise Tech Svcs
MRGRX58.130.01
+0.02%
MFS Core Equity I
VLSCX16.54N/A
N/A
Virtus KAR Long/Short Equity C
YCGEX32.29-0.04
-0.12%
YCG Enhanced
FMEFX42.64-0.20
-0.47%
Nuveen Small/Mid Cap Growth Opp R6

EMBC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, EMBC has been loosely correlated with NEOG. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if EMBC jumps, then NEOG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EMBC
1D Price
Change %
EMBC100%
-0.71%
NEOG - EMBC
37%
Loosely correlated
-2.47%
AZTA - EMBC
36%
Loosely correlated
-2.96%
IRMD - EMBC
35%
Loosely correlated
-1.32%
GMED - EMBC
33%
Loosely correlated
-2.10%
MTD - EMBC
33%
Loosely correlated
-0.90%
More